GE HealthCare Technologies on Thursday forecast annual profit above Wall Street estimates, counting on strong demand for its ...

Wells Fargo analyst Larry Biegelsen raised the firm’s price target on GE HealthCare (GEHC) to $103 from $96 and keeps an Overweight rating on ...

GE HealthCare Technologies Inc. closed 2.73% short of its 52-week high of $94.80, which the company achieved on February 13th.

GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2024. GE HealthCare President an ...

Reports Q4 revenue $5.32B, consensus $5.33B. GE HealthCare President and CEO Peter Arduini said, “We were pleased with the strong momentum in orders, backlog and book-to-bill th ...

Wuensch rates GE HealthCare stock at Buy with a $103 price target. Coming into Thursday, GE HealthCare stock has risen about ...

GE HealthCare has announced a $138m investment to expand its contrast media manufacturing site in Carrigtohill, Cork, Ireland. Contrast media are injectable diagnostic imaging agents used to ...

GE HealthCare and the University of California ... collaborative research initiative for medical imaging, known as the ‘Care Innovation Hub’. The initiative aims to tackle clinical challenges ...

The agreement, dubbed Care Alliance, marks one of GE HealthCare’s largest-ever enterprise strategic partnerships, the companies said in a press release. Bloomberg reported that the strategic ...

GE HealthCare has announced a €132m investment to expand its facility in Cork where they manufacture contrast media - diagnostic imaging agents used in CT scans and X-Rays. A new 3000m2 facility ...

Shares of GE HealthCare (NASDAQ:GEHC) jumped 9% Thursday after the company issued its Q4 earnings report and 2025 forecast. For Q4, the company posted non-GAAP EPS of $1.45 on revenue of $5.32B.

GE HealthCare Technologies shows bullish price action with higher highs and lows, trading above its 30-week EMA, but EMA isn't trending higher yet. Momentum is currently bearish both short and ...